In Brief: FDA Gastrointestinal Drugs Advisory Committee

Executive Summary

FDA Gastrointestinal Drugs Advisory Committee: Meeting July 12 to discuss Lemmon's NDA 20-458 for zinc acetate for treatment of Wilson's disease and draft "Points to Consider" on H. pylori studies to prevent peptic ulcer recurrence. The meeting will take place at the Holiday Inn-Bethesda, Md., beginning at 9 a.m. A joint meeting of the GI Drugs committee with the Nonprescription Drugs Advisory Committee will take place on July 13 to discuss Glaxo's NDA 20-520 for an Rx-to-OTC switch of Zantac 75 for treatment of heartburn. The meeting begins at 8:30 a.m. in conference rooms D&E of FDA's Parklawn building...